Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy - Concepedia

Concepedia

Publication | Closed Access

Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy

192

Citations

25

References

2006

Year

M. Marty, Marc Espié, Alain Monnier, Bernardo L. Rapoport, V. Stahalova

Annals of Oncology

Breast OncologyOncologyMedicineAnthracycline-based ChemotherapyBreast CancerPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyPhase Iii StudyCardioprotective Effect

References

	Year	Citations

Page 1